The role of toxicity-related regimen changes in the development of antiretroviral resistance - Wikidata - awgldk - TriplyDB

The role of toxicity-related regimen changes in the development of antiretroviral resistance

The role of toxicity-related regimen changes in the development of antiretroviral resistance

http://www.wikidata.org/entity/Q35330053

about

Factors Associated with Missed Psychiatry Visits in an Urban HIV Clinic.Reasons and predictors for antiretroviral therapy change among HIV-infected adults at South West Ethiopia.

P2860

Q39079045-4C64DF97-C7DB-4FAC-87DB-B01398962F90 Q55257500-8C64EC89-38DD-4D1F-A6A1-C463378A3B4D

P2860

The role of toxicity-related regimen changes in the development of antiretroviral resistance

http://www.wikidata.org/entity/Q35330053

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The role of toxicity-related r ...... t of antiretroviral resistance

@ast

The role of toxicity-related r ...... t of antiretroviral resistance

@en

type

label

The role of toxicity-related r ...... t of antiretroviral resistance

@ast

The role of toxicity-related r ...... t of antiretroviral resistance

@en

prefLabel

The role of toxicity-related r ...... t of antiretroviral resistance

@ast

The role of toxicity-related r ...... t of antiretroviral resistance

@en

P1433

Q35330053-75A9E621-A368-48FF-BEF4-9506D65DD734

P1476

Q35330053-C66F221C-ACC5-4163-923B-737AF399F7E5

P2093

Q35330053-340FED1C-06DA-45B6-AB67-DBC868937E89

Q35330053-73EBD1BB-CEA9-47D3-B1AE-E8AC0B6FAC2C

Q35330053-79AE3619-8C23-4489-A8EA-E829AE9383EE

Q35330053-8871F49C-3F04-43A4-BFF1-3589396616AF

Q35330053-B1F3C0B6-AC60-470E-A519-66B3EDF27E50

Q35330053-D01046F5-0B26-40AC-AAAB-800E2890C421

Q35330053-F44F0813-4C5D-4BAF-A6A2-CF791F218B62

Q35330053-FFA8CFBE-F98F-4F36-8FE3-8E5FBEFB10AB

P2860

Q35330053-00242919-A506-44BF-8E32-F4C04A08D942

Q35330053-01C691B9-3CD7-48D0-800C-8763AB82C4BC

Q35330053-0D6ECBA9-C807-4998-BC1A-2928191671C8

Q35330053-10CA15CE-72EA-4F5A-BFFD-E7D89414C2FA

Q35330053-1A6A21C7-72F6-4DC0-8532-3C91D6F9E114

Q35330053-2081E539-6F7B-4F7F-BF6E-4E9C8189A960

Q35330053-2733E0A3-59DE-4F2C-8B13-92BE22BFD8A5

Q35330053-2928F82E-06F9-4112-8B68-304D76E9A7D5

Q35330053-38FC9E81-E93B-4FA1-B1DD-F0E7616AEB68

Q35330053-4274254E-7A81-4956-AA84-C12B94B79786

P304

Q35330053-76F8436C-EE0A-41CD-9C6C-0F03420C4B1A

P31

Q35330053-3A5F6AA9-F2B8-4610-A9D1-FB9AF4C51A30

P356

Q35330053-BFDD8A5C-88D7-429F-B3FF-CEEE21EC2287

P433

Q35330053-C6117B91-EF01-4425-9141-D18F11F40282

P478

Q35330053-984B6EE8-A76E-44EB-A3AB-B7CEB4B0A868

P50

Q35330053-701BFC0E-7DB4-43D6-9BD4-449785E76A50

Q35330053-DCE486DD-A1A4-4024-AE08-34060163BA93

P577

Q35330053-FEF8317E-14AB-4C04-9682-C3F0C46F4DC5

P698

Q35330053-08DC56F9-38D0-40B9-8FF8-24A55CEED7EC

P921

Q35330053-E8B8CC89-6088-43AE-96C1-CFB40632F1A6

P932

Q35330053-2C25DB81-0BD7-4773-A582-5D7CB79B8988

P356

P1433

AIDS Research and Human Retroviruses

P1476

The role of toxicity-related r ...... t of antiretroviral resistance

@en

P2093

Christa R Nevin

http://www.w3.org/2001/XMLSchema#string

David Jackson

http://www.w3.org/2001/XMLSchema#string

Inmaculada Aban

http://www.w3.org/2001/XMLSchema#string

James H Willig

http://www.w3.org/2001/XMLSchema#string

James L Raper

http://www.w3.org/2001/XMLSchema#string

Jiatao Ye

http://www.w3.org/2001/XMLSchema#string

Michael J Mugavero

http://www.w3.org/2001/XMLSchema#string

Michael S Saag

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.

Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy

Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy.

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

Racial disparities in HIV virologic failure: do missed visits matter?

P304

957-963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2010.0291

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Jeroan J. Allison

P577

2011-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21342052

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3192056

http://www.w3.org/2001/XMLSchema#string